IDYA
IDYA
NASDAQ · Biotechnology

Ideaya Biosciences Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$31.23
-0.03 (-0.10%)
As of Jun 21, 9:59 PM ET ·
Analyst Consensus
Strong Buy
25
Analysts
High
Coverage
Buy 22 88%
Hold 3 12%
Sell 0 0%
Price Target
Analyst Price Target +276.8% upside
Low Target $81.99
Average Target $117.67
High Target $158.58
Current Price $31.23
Current
$31.23
Target
$117.67
$81.99 $117.67 avg $158.58
Scenario Analysis
Bear Case
$81.99
162.5%
Low target
Base Case
$117.67
+276.8%
Avg target
Bull Case
$158.58
+407.8%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$39.28
-20.5% from high
52-Week Low
$20.50
+52.3% from low
50-Day SMA
$34.24
-8.8% vs SMA
200-Day SMA
$27.52
+13.5% vs SMA
RSI (14)
49.6
Neutral
Target vs 52W High
$117.67
+199.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +12.0%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -44.6%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +190.4%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -6.1%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.5%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -64.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -31.2%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -37.5%